Economic analysis of treatment of functional dyspepsia: An assessment of the quality of published studies

International Journal of Technology Assessment in Health Care

Volumn 17, Issue 4, 2001, Pages 517-527

  García Altés, Anna ^a   Jovell, Esther ^b  

^a Catalan Agency for Health Technology Assessment and Research   (Spain)

^b Brain   (Spain)

Author keywords

Economic analysis; Functional dyspepsia; Outcome measure; Scientific evidence

Indexed keywords

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DYSPEPSIA; GASTROINTESTINAL DISEASE; HEALTH CARE COST; HEALTH ECONOMICS; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; OUTCOMES RESEARCH; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

EID: 0035204546     PISSN: 02664623     EISSN: None     Source Type: Journal    
DOI: 10.1017/s0266462301107075     Document Type: Article

References (45)

1. Cost of illness studies in health care: A comparison of two cases
2. Uncertainty in the economic evaluation of health care technologies: The role of sensitivity analysis
3. Handling uncertainty in economic evaluations of healthcare interventions
4. Cost effectiveness of screening for and eradication of Helicobacter pylori in management of dyspeptic patients under 45 years of age
5. The Omega Project. A comparison of two diagnostic strategies for risk- and cost-oriented management of dyspepsia
6. Modelling in economic evaluation: An unavoidable fact of life
7. 2-blocker therapy or prompt endoscopy in management of dyspepsia
8. Management of dyspepsia: Report of a working party
9. Current status of economic appraisal of health technology in the European community: Report of the network. The EC Network on the Methodology of Economic Appraisal of Health Technology
10. US householder survey of functional gastrointestinal disorders: Prevalence, sociodemography, and health impact
11. Evaluation of the dyspeptic patient: A cost-utility study
12. Criteria list for quality assessment of economic evaluation reviews
13. Alternative management strategies for patients with suspected peptic ulcer disease
14. Immediate endoscopy or initial Helicobacter pylori serological testing for suspected peptic ulcer disease: Estimating cost-effectiveness using decision analysis
15. 2-receptor antagonists in patients with dyspepsia and heartburn: A cost comparison
16. Evidencia científica y análisis económico: ¿dos conceptos excluyentes?
17. Evaluación de la evidencia científica
18. Management in general practice of patients with persistent dyspepsia: A decision analysis
19. Randomised controlled trial of omeprazole or endoscopy in patients with persistent dyspepsia: A cost-effective analysis
20. Long-term costs after gastroenterology consultation with endoscopy versus radiography in dyspepsia
21. Reporting guidelines for economic studies
22. New patients presenting to their GP with dyspepsia: Does Helicobacter pylori eradication minimise the cost of managing these patients?
23. Management strategies for Helicobacter pylori-seropositive patients with dyspepsia: Clinical and economic consequences
24. Evaluation of initial noninvasive therapy in pediatric patients presenting with suspected ulcer disease
25. Meta-analysis of economic evaluations: A methodological approach and case-study
26. Developing a quality assessment scoring system for economic evaluations
27. Diagnosis and treatment of dyspepsia: A cost-effectiveness analysis
28. Standardizing economic appraisal of health technologies in the European Union
29. A critical review of health-related economic evaluations in Australia: Implications for health policy
30. Use of non-antacid antiulcer agents in the treatment of heartburn and dyspepsia
31. Economic evaluation of diagnostic tests
32. Estimating the cost of lost productivity in dyspepsia
33. Problems of using modelling in the economic evaluation of health care
34. Initial endoscopy or empirical therapy with or without testing for Helicobacter pylori for dyspepsia: A decision analysis
35. Cost-benefit analysis of testing for Helicobacter pylori in dyspeptic subjects
36. Economic analysis of dyspepsia
37. Issues concerning the sources of effectiveness data used in economic evaluations included in the National Health Service Economic Evaluation Database (NHS EED)
38. Cost-effectiveness and cost-benefit analyses in the medical literature. Are the methods being used correctly?
39. Cost-effectiveness of noninvasive testing and treatment strategies for H. pylori infection in children with dyspepsia